(Q43801171)

26 November 2017

title

6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors (English)

1 reference

26 November 2017

Hodgetts KJ

1

1 reference

26 November 2017

Kieltyka A

2

1 reference

26 November 2017

Brodbeck R

3

1 reference

26 November 2017

Tran JN

4

1 reference

26 November 2017

Wasley JW

5

1 reference

26 November 2017

Thurkauf A

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bioorganic & Medicinal Chemistry

26 November 2017

published in

1 reference

26 November 2017

volume

9

1 reference

26 November 2017

issue

12

1 reference

26 November 2017

page(s)

3207-3213

1 reference

The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

D4 receptors and their antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Full-length cDNA cloning and distribution of human dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

Current and novel approaches to the drug treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900226-7

7 January 2021

10.1016/S0968-0896(01)00226-7

Identifiers

DOI

1 reference

26 November 2017

1 reference